¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nitric acid reductase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • hydrofluoric acid
    ºÒÈ­¼ö¼Ò»ê
  • hydroxyindoleacetic acid
    È÷µå·Ï½ÃÀε¹¾Æ¼¼Æ®»ê
  • isothiocyanic acid
    ÀÌ¼ÒÆ¼¿À½Ã¾È»ê
  • inosinic acid
    À̳ë½Å»ê
  • ketonic acid
    ÄÉÅæ»ê
  • lauric acid
    ·Î¸£»ê
  • leuconic acid
    ·ùÄÜ»ê
  • lichenic acid
    ÁöÀÇ»ê
  • linoleic acid
    ¸®³î·¹»ê
  • linolenic acid
    ¸®³î·»»ê
  • linolic acid
    ¸®³î»ê
  • lipoic acid
    ¸®Æ÷»ê
  • lactic acid
    Á¥»ê
  • mixed acid
    È¥ÇÕ»ê
  • maleic acid
    ¸»·¹»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • neurostearic acid
    ½Å°æÁö¹æ»ê
  • nicotinic acid
    ´ÏÄÚÆ¾»ê
  • nitrobenzoic acid
    ³ªÀÌÆ®·Îº¥Á¨»ê
  • nitrohydrochloric acid
    Áú¿°»ê, ¿Õ¼ö
  • nitrous acid
    Áú»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • nucleic acid
    ÇÙ»ê
  • oleic acid
    ¿Ã·¹»ê
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • oxaloacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
  • pantoic acid
    ÆÇÅäÀλê
  • pantothenic acid
    ÆÇÅäÅÙ»ê
  • phenolic acid
    Æä³î»ê
  • phenolsulfuric acid
    Æä³îȲ»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • acid<³ª> acidus
    »ê(ß«), »ê¼º(ß«àõ)ÀÇ.
  • adenylic acid deaminase
    ¾Æµ¥´Ò»ê Å»¾Æ¹Ì³ëÈ¿¼Ò.
  • aliphatic acid
    Áö¹æÁ·»ê(ò·Û¸ðéß«).
  • aliphatic amino acid
    Áö¹æÁ·¾Æ¹Ì³ë»ê
  • aloetic acid
    ¾Ë·Î¿¡Æ¾»ê.
  • alpha-amino acid nitrogen
    ¾ËÆÄ-¾Æ¹Ì³ë»êÁú¼Ò
  • alpha1-acid glycoprotein
    ¾ËÆÄ-»ê´ç´Ü¹é
  • amino acid
    ¾Æ¹Ì³ë»ê
  • amino acid analyzer
    ¾Æ¹Ì³ë»êºÐ¼®±â
  • amino acid determination
    ¾Æ¹Ì³ë»ê°áÁ¤(̽ïÒ)
  • amino acid pattern
    ¾Æ¹Ì³ë»êÇüÅÂ
  • amino acid sequence
    ¾Æ¹Ì³ë»ê ¼­¿­.
  • aminoacetic acid<³ª> acidum aminoaceticum
    ¾Æ¹Ì³ë¾Æ¼¼Æ®»ê.
  • aminohippuric acid
    ¾Æ¹Ì³ë ¸¶´¢»ê
  • anaphylaxis,arachidonic acid metabolitesin
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú(¡­ß« ÓÛÞóÚªòõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • arginine-glycine-aspartic acid
    Arginine-glycine-aspartic acid
  • aromatic amino acid
    ¹æÇâÁ·¾Æ¹Ì³ë»ê.
  • arormatic amino acid
    ¹æÇâÁ·¾Æ¹Ì³ë»ê
  • arsenic acid
    ºñ»ê(Ý÷ß«).
  • arsenoacetic acid
    ¾Æ¸£¼¼³ë¾Æ¼¼Æ®»ê.
  • arsenous acid
    ¾Æºñ»ê(ä¬Ý÷ß«).
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê.
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê(¡­ß«)
  • ascorbic acid = vitamin C
    ¾Æ½ºÄÚ¸£ºó»ê = ºñŸ¹Î C
  • available phosphoric acid
    À¯È¿Àλê.
  • bacterium, acid-fast
    Ç×»ê±Õ, Ç׻긷´ë±Õ, AFB
  • bacterium, lactic acid
    À¯»ê¼¼±Õ
  • basal acid output
    ±âÀú»ê¹èÃâ·®
  • benzoic acid
    º¥Á¶»ê
  • benzoic acid
    º¥Á¶»ê.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • deoxyadenylic acid
    µ¥¿Á½Ã¾Æµ¥´Ò»ê(ß«)
  • deoxycholic acid
    µ¥¿Á½ÃÄÝ»ê(ß«)
  • deoxycytidylic acid
    µ¥¿Á½Ã»çÀÌÆ¼µô»ê(ß«)
  • deoxyguanylic acid
    µ¥¿Á½Ã±¸¾Æ´Ò»ê(ß«)
  • deoxyribonucleic acid
    µ¥¿Á½Ã¶óÀ̺¸ÇÙ»ê(ß«)
  • deoxyribose nucleic acid
    "µ¥¿Á½Ã¶óÀ̺¸½º ÇÙ»ê(ú·ß«), (ÔÒ) deoxyribonucleic acid"
  • deoxythymidylic acid
    "µ¥¿Á½ÃŸÀ̵̹ô»ê(ß«), (ÔÒ) thymidylic acid"
  • deoxyuridylic acid
    µ¥¿Á½ÃÀ¯¸®µô»ê
  • deuridylic acid
    Å»(÷­)À¯¸®µô »ê(ß«)
  • dicarboxylic acid cycle
    "ÀÌ(ì£)Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ), (ÔÒ) glyoxylate cycle"
  • "2,4-dichlorophenoxyacetic acid"
    "2,4-ÀÌ(ì£)¿°¼Ò(ç¤áÈ)Æä³ì½Ã¾Æ¼¼Æ®»ê(ß«)"
  • "2,6-dichlorophenoxyacetic acid"
    "2,6-ÀÌ(ì£)¿°¼Ò(ç¤áÈ)Æä³ì½Ã¾Æ¼¼Æ®»ê(ß«)"
  • "2,5-dihydroxyphenylacetic acid"
    "2,5-ÀÌ(ì£)ÇÏÀ̵å·Ï½ÃÆä´Ò¾Æ¼¼Æ®»ê(ß«) (ÔÒ) homogentisic acid"
  • dinitrophenyl amino acid
    ÀÌ(ì£)´ÏÆ®·ÎÆä´Ò ¾Æ¹Ì³ë»ê(ß«)
  • "1,3-diphosphoglyceric acid"
    "1,3-ÀÌÀλê(ì£×òß«)±Û¸®¼¼¸°»ê(ß«), (ÔÒ) 1,3-bisphosphoglycerate"
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
GSR galvanic skin response; generalized Shwartzman reaction; glutathione reductase
GSSG-R glutathione reductase
17-KSR 17-ketosteroid reductase
MHR major histocompatibility region; malignant hyperthermia resistance; maternal heart rate; maximal hea...
MR Maddox rods; magnetic resistance; magnetic resonance; mandibular reflex; mannose-resistant; may repe...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
NO Synthase nitric oxide synthase
NOS-3 nitric oxide synthase
MTHFR 10-Methylenetetrahydrofolate reductase
HMGR 3-Hydroxy-3-methylglutaryl CoA reductase
HMGR 3-Hydroxy-3-methylglutaryl coenzyme A reductase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lactic acid formation
    À¯»ê Çü¼º
  • lactonic acid
    ¶ôÅæ »ê
    À¯´ç. ¾Æ¶óºñ¾Æ °í¹«. °¥¶ôÅ佺¸¦ »êÈ­ÇÔÀ¸·Î½á ¾ò¾îÁø´Ù.
  • lanopalmic acid : ¾ç¸ðÁö¿¡ µé¾î ÀÖ´Â 1¼ö»ê±â¼ºÀÇ Æ÷È­ Áö¹æ»ê.

    lanosterol

    ¶ó³ë½ºÅ×·Ñ
    ¾ç¸ðÁö¿¡ µé¾î ÀÖ´Â ½ºÅ×·ÑÀÇ ÀÏÁ¾.
  • larinolic acid
    ¶ó¸®³î »ê
  • linolic acid
    ¸®³î»ê
  • lymphocantric acid
    ¸²Æ÷Ä­Æ®¸£»ê
    Àӯļº ¹éÇ÷º´ ȯÀÚÀÇ ¿ä¿¡¼­ ÃßÃâµÈ´Ù.
  • lysalbinic acid
    ¸®»ìºó »ê
    ³­¹éÀ» °¡¼º ¼Ò¿À´Ù·Î ó¸®ÇÔÀ¸·Î½á ¾ò¾îÁö´Â »ê.
  • lysergic acid
    ¸®À縣±×»ê
    ¸Æ°¢ ¾ËÄ®·ÎÀ̵åÀÇ ¸ðü·Î, ±× À̼ºÃ¼ÀÎ ÀÌ¼Ò ¸®Á¦¸£±×»ê°ú ÇÔ²² Æ®¸®ÆéƼµå ¶Ç´Â ¾Æ¹Ì³ë ÇÁ·ÎÆÄ³î°ú °áÇÕÇÏ¿© ¸Æ°¢ ¾ËÄ®·ÎÀ̵å·ù¸¦ Çü¼ºÇÑ´Ù.
  • lyxonic acid
    ¸¯¼Õ»ê
  • maleic acid
    ¸»·¹»ê, ¸»·¹Àλê
    ºÒÆ÷È­ ÀÌ¿°±â»ê.
  • malic acid
    ´É±Ý»ê
    µ¿ÀǾî=hydroxysuccinic acid. Æ®¶óÀÌÄ«¸£º¹½Ç»ê ȸ·ÎÀÇ Áß°£ ¹°Áú. ´ú ÀÍ°í ½Å »ç°ú¿Í ´Ù¸¥ ¸¹Àº °ú½Ç ¼Ó¿¡ µé¾îÀÖ´Ù. ±«Ç÷º´ÀÇ Ä¡·á¿¡ »ç¿ëµÇ±âµµ ÇÑ´Ù.
  • malonic acid
    ¸»·Ð»ê
    °áÁ¤¼ºÀÇ ÀÌ¿°±â»ê.
  • meclofenamic acid
    ¸ÞŬ·ÎÆä³ª¹Ìµå»ê
    °ñ°üÀý¿° ¹× ·ù¸¶ÅäÀÌµå °üÀý¿°ÀÇ Ä¡·á¿¡ meclofenamate sodiumÀ¸·Î »ç¿ëµÈ´Ù.
  • meconic acid
    ¸ÞÄÜ»ê
    ¹é»ö °áÁ¤¼º »ê.
  • mefenamic acid
    ¸ÞÆä³²»ê
    °áÁ¤¼º ºÐ¸», ÇÔ¿°ÁõÁ¦.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
progesterone reductase <enzyme> An enzyme that catalyses the reduction of a 3 beta-hydroxy-delta(5)-steroid to 3-oxo-delta(4)-steroid in the presence of NAD. It converts pregnenolone to progesterone and dehydroepiandrosterone to androstenedione.45.
Chemical name: 3 beta-Hydroxy-delta(5)-steroid:NAD+ 3-oxidoreductase
Registry number: EC 1.1.1.145
(12 Dec 1998)
sarcosine reductase <enzyme> Involved in sarcosine metabolism in eubacterium acidaminophilum
Registry number: EC 1.4.4.-
Synonym: n-methylglycine reductase
(26 Jun 1999)
prostaglandin-E2 9-reductase <enzyme> Catalyses reversibly an nad+ dependent oxidation of the 9alpha-hydroxyl group of 15-keto-13,14-dihydro-pgf2alpha to 15-keto-13,14-dihydro-pge2; also acts on pga1; sequence data indicates that it is identical with carbonyl reductase (NADPH) (EC 1.1.1.184)
Registry number: EC 1.1.1.189
Synonym: 9-ketoprostaglandin reductase, prostaglandin-9-hydroxydehydrogenase, pge2 9-ketoreductase, pge 9-ketoreductase, prostaglandin e2-9-oxoreductase, prostaglandin 9-ketoreductase, prostaglandin e2-9-ketoreductase, 9-hydroxy-pg dehydrogenase, 9-hydroxyprostaglandin dehydrogenase, pge2 9-reductase
(26 Jun 1999)
protein disulfide reductase (glutathione) <enzyme> An enzyme that catalyses the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates.
Chemical name: Glutathione:protein-disulfide oxidoreductase
Registry number: EC 1.8.4.2
(12 Dec 1998)
heterodisulfide reductase <enzyme> A two-subunit cytochrome b-containing enzyme from methanol-grown methanosarcina barkeri; catalyses the terminal step in the energy-conserving electron transport chain in methanogenic archaea; has been sequenced; authors give EC number as 1.99.4.- (not in enzyme nomenclature)
Registry number: EC 1.12.99.-
(26 Jun 1999)
xylulose reductase <enzyme> An enzyme that reversibly converts xylulose to xylitol using either NADH (d-xylulose reductase) or NADPH (l-xylulose reductase); a deficiency of the l-form is seen in individuals with essential pentosuria.
Synonym: xylitol dehydrogenase.
(05 Mar 2000)
HMG CoA reductase inhibitor Drugs, such as lovastatin and pravastatin, which interfere with the biosynthesis of cholesterol; used to treat hyperlipidemia.
(05 Mar 2000)
HMG-CoA reductase phosphatase <enzyme> Similar to phosphoprotein phosphatase, EC 3.1.3.16
Registry number: EC 3.1.3.-
Synonym: 3-hydroxy-3-methylglutaryl coenzyme a reductase phosphatase
(26 Jun 1999)
selenate reductase <enzyme> Terminal electron acceptor for anaerobic respiration in thauera selenatis; reduces selenate to selenite
Registry number: EC 1.97.-
(26 Jun 1999)
pyrroline-2-carboxylate reductase An oxidoreductase reducing 1-pyrroline-2-carboxylate to l-proline with NAD(P)H.
Synonym: proline dehydrogenase, proline oxidase.
(05 Mar 2000)
pyrroline-5-carboxylate reductase An oxidoreductase reversibly reducing 1-pyrroline-5-carboxylate to l-proline with NAD(P)H; a deficiency of this enzyme is associated with type I hyperprolinaemia.
Synonym: proline dehydrogenase, proline oxidase.
(05 Mar 2000)
hydrogensulfite reductase <enzyme> Catalyses the reduction of sulfite mainly to trithionate with concomitant formation of thiosulfate and sulfide in the dissimilatory sulfate reduction pathway; see also trithionate reductase system
Registry number: EC 1.8.99.3
Synonym: bisulfite reductase, dissimilatory sulfite reductase, desulfoviridin, desulforubidin, desulfofuscidin
(26 Jun 1999)
hydroxymethylglutaryl-CoA reductase inhibitors Compounds that inhibit hmg-CoA reductases. They have been shown to directly lower cholesterol synthesis.
(12 Dec 1998)
sodium-translocating NADH-quinone reductase <enzyme> From vibrio alginolyticus; na+ dependent activation is located in the NADH-quinone reductase segment; reduces ubiquinone-1 to ubisemiquinones or ubiquinol; strongly inhibited by 2-n-heptyl-4-hydroxyquinoline n-oxide; do not confuse with sodium independent NADH-quinone reductase EC 1.6.99.2
Registry number: EC 1.6.5.-
Synonym: nqr-1, na-translocating NADH-quinone reductase, nqr gene product
(26 Jun 1999)
S-phenacylglutathione reductase <enzyme> Toxic alpha-haloketones react nonenzymatically to form s-phenacylglutathione which is reduced to the corresponding non-toxic alkylketone
Registry number: EC 1.8.4.-
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á